Annual Retained Earnings
-$194.97 M
-$6.68 M-3.55%
31 December 2023
Summary:
Entrada Therapeutics annual retained earnings is currently -$194.97 million, with the most recent change of -$6.68 million (-3.55%) on 31 December 2023. During the last 3 years, it has fallen by -$101.30 million (-108.15%). TRDA annual retained earnings is now -1119.48% below its all-time high of -$15.99 million, reached on 31 December 2019.TRDA Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$130.47 M
-$14.03 M-12.05%
30 September 2024
Summary:
Entrada Therapeutics quarterly retained earnings is currently -$130.47 million, with the most recent change of -$14.03 million (-12.05%) on 30 September 2024. Over the past year, it has increased by +$64.50 million (+33.08%). TRDA quarterly retained earnings is now -206.92% below its all-time high of -$42.51 million, reached on 31 December 2020.TRDA Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TRDA Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +33.1% |
| 3 y3 years | -108.2% | -39.3% |
| 5 y5 years | -1119.5% | - |
TRDA Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -108.2% | at low | -39.3% | +40.9% |
| 5 y | 5 years | -1119.5% | at low | -206.9% | +40.9% |
| alltime | all time | -1119.5% | at low | -206.9% | +40.9% |
Entrada Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$130.47 M(+12.1%) |
| June 2024 | - | -$116.44 M(-32.1%) |
| Mar 2024 | - | -$171.47 M(-12.1%) |
| Dec 2023 | -$194.97 M(+3.6%) | -$194.97 M(+5.1%) |
| Sept 2023 | - | -$185.43 M(-16.1%) |
| June 2023 | - | -$220.89 M(+13.3%) |
| Mar 2023 | - | -$194.96 M(+3.5%) |
| Dec 2022 | -$188.28 M | -$188.28 M(+15.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | -$163.66 M(+18.1%) |
| June 2022 | - | -$138.52 M(+20.1%) |
| Mar 2022 | - | -$115.34 M(+23.1%) |
| Dec 2021 | -$93.67 M(+120.3%) | -$93.67 M(+24.5%) |
| Sept 2021 | - | -$75.22 M(+23.7%) |
| June 2021 | - | -$60.79 M(+43.0%) |
| Dec 2020 | -$42.51 M(+165.9%) | -$42.51 M |
| Dec 2019 | -$15.99 M | - |
FAQ
- What is Entrada Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly retained earnings year-on-year change?
What is Entrada Therapeutics annual retained earnings?
The current annual retained earnings of TRDA is -$194.97 M
What is the all time high annual retained earnings for Entrada Therapeutics?
Entrada Therapeutics all-time high annual retained earnings is -$15.99 M
What is Entrada Therapeutics quarterly retained earnings?
The current quarterly retained earnings of TRDA is -$130.47 M
What is the all time high quarterly retained earnings for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly retained earnings is -$42.51 M
What is Entrada Therapeutics quarterly retained earnings year-on-year change?
Over the past year, TRDA quarterly retained earnings has changed by +$64.50 M (+33.08%)